Rapport Therapeutics (NASDAQ:RAPP) CEO Sells $93,063.10 in Stock
MarketBeat
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) CEO Abraham Ceesay sold 2,210 shares of the company's stock in a transaction on Monday, July 27th. The shares were sold at an average price of $42.11, for a total value of $93,063.10. Following the completion of the transaction, the chief executive officer directly owned 537,607 shares in the company, valued at approximately $22,638,630.77. This trade represents a 0.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
NASDAQ:RAPP